CAS: 2070009-55-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PF-2771 REF: TM-T12434CAS: 2070009-55-9 | 98% | 1,394.00 € | Mon 03 Feb 25 | |
N-[(2S)-1-[4-(2-Acetyl-1-methylimidazol-4-yl)phenyl]-3-[[2-(dimethylamino)acetyl]amino]propan-2-yl]-3-chloro-4-propan-2-yloxybenzami de REF: 3D-VHD00955CAS: 2070009-55-9 | Min. 95% | - - - | Discontinued product |
PF-2771
CAS:2070009-55-9
PF-2771: potent CENP-E inhibitor, IC50 of 16.1 nM, used in cancer treatment.
Formula:
C29H36ClN5O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
554.08
Ref: TM-T12434
100mg | 1,394.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
N-[(2S)-1-[4-(2-Acetyl-1-methylimidazol-4-yl)phenyl]-3-[[2-(dimethylamino)acetyl]amino]propan-2-yl]-3-chloro-4-propan-2-yloxybenzami de
CAS:2070009-55-9
Please enquire for more information about N-[(2S)-1-[4-(2-Acetyl-1-methylimidazol-4-yl)phenyl]-3-[[2-(dimethylamino)acetyl]amino]propan-2-yl]-3-chloro-4-propan-2-yloxybenzami de including the price, delivery time and more …
Formula:
C29H36ClN5O4
Purity:
Min. 95%
Molecular weight:
554.1 g/mol
Ref: 3D-VHD00955
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |